scholarly journals Effect of the S -nitrosoglutathione reductase inhibitor N6022 on bronchial hyperreactivity in asthma

2018 ◽  
Vol 6 (2) ◽  
pp. 322-331 ◽  
Author(s):  
Loretta G. Que ◽  
Zhonghui Yang ◽  
Njira L. Lugogo ◽  
Rohit K. Katial ◽  
Steven A. Shoemaker ◽  
...  
Keyword(s):  
Reductase Inhibitor ◽  
Bronchial Hyperreactivity

Inhibition of airways inflammation by dexamethasone is followed by reduced bronchial hyperreactivity in BP2 mice

1996 ◽  
Vol 26 (8) ◽  
pp. 971-979
Author(s):  
S.-Y. EUM ◽  
C. CREMINON ◽  
S. HAILE ◽  
J. LEFORT ◽  
B. B. VARGAFTIG
Keyword(s):  
Bronchial Hyperreactivity ◽  
Airways Inflammation

186-OR: Safety and Tolerability of the Next Generation Aldose Reductase Inhibitor (ARI) AT-001 Supports Initiation of the Pivotal Trial in Diabetic Cardiomyopathy (DbCM)

Diabetes ◽  
2020 ◽  
Vol 69 (Supplement 1) ◽  
pp. 186-OR
Author(s):  
RICCARDO PERFETTI ◽  
FRANCESCA C. LAWSON ◽  
JULIO ROSENSTOCK ◽  
JAMES JANUZZI ◽  
SHOSHANA SHENDELMAN ◽  
...  
Keyword(s):  
Aldose Reductase ◽  
Diabetic Cardiomyopathy ◽  
Reductase Inhibitor ◽  
Aldose Reductase Inhibitor ◽  
Pivotal Trial ◽  
Next Generation

462-P: AT-001, a Next Generation Aldose Reductase Inhibitor with Improved Selectivity and Specificity, Protects from Cellular Damage Associated with Hyperglycemia

Diabetes ◽  
2020 ◽  
Vol 69 (Supplement 1) ◽  
pp. 462-P
Author(s):  
RICCARDO PERFETTI ◽  
GAUTHAM YEPURI ◽  
NOSIRUDEEN A. QUADRI ◽  
RAVICHANDRAN RAMASAMY ◽  
AMEEN F. GHANNAM ◽  
...  
Keyword(s):  
Aldose Reductase ◽  
Reductase Inhibitor ◽  
Aldose Reductase Inhibitor ◽  
Cellular Damage ◽  
Next Generation

Simvastatin, an HMG–Coenzyme A Reductase Inhibitor, Improves Endothelial Function Within 1 Month

Circulation ◽  
1997 ◽  
Vol 95 (5) ◽  
pp. 1126-1131 ◽  
Author(s):  
Gerard O'Driscoll ◽  
Danny Green ◽  
Roger R. Taylor
Keyword(s):  
Endothelial Function ◽  
Reductase Inhibitor ◽  
Coenzyme A ◽  
Coenzyme A Reductase

Targeted co-delivery of the aldose reductase inhibitor epalrestat and chemotherapeutic doxorubicin via a redox-sensitive prodrug approach promotes synergistic tumor suppression

2019 ◽  
Vol 7 (7) ◽  
pp. 2889-2906 ◽  
Author(s):  
Venkatesh Teja Banala ◽  
Sandeep Urandur ◽  
Shweta Sharma ◽  
Madhu Sharma ◽  
Ravi P. Shukla ◽  
...  
Keyword(s):  
Aldose Reductase ◽  
Tumor Suppression ◽  
Reductase Inhibitor ◽  
Aldose Reductase Inhibitor ◽  
Down Regulation ◽  
Redox Responsive

Redox responsive epalrestat prodrug micelles facilitate synergistic concentrations of doxorubicin with an advantage of CD44 down-regulation and reduced cardiotoxicity.

Sign in / Sign up

Export Citation Format

Share Document